Work

Dupilumab Reduces Exacerbations and Improves Lung Function and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation: the Notus Trial

Year: 2024

Type: article

Source: CHEST Journal

DOI: 10.1016/j.chest.2024.06.2868

Authors: SURYA P BHATT, KLAUS F RABE, NICOLA A HANANIA, CLAUS VOGELMEIER, MONA BAFADHEL, STEPHANIE CHRISTENSON, ALBERTO PAPI, DAVE SINGH, ELIZABETH LAWS, BOLANLE AKINLADE, JENNIFER MALONEY, XIN LU, DEBORAH BAUER, ASHISH BANSAL, RAOLAT ABDULAI, LACEY ROBINSON

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: AstraZeneca, GlaxoSmithKline, Sanofi, CSL Behring, Insmed, Grifols

OpenAlex ID: W4402601229

FWCI: 0.251

Cites:

Cited by: 1

Related to: 10